Integra LifeSciences to Hold Second International Tissue Technologies Symposium on June 15 - 16, 2017 in Berlin, Germany
June 15 2017 - 03:00AM
PLAINSBORO, N.J., June 15, 2017 (GLOBE NEWSWIRE)
-- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today
announced that it is holding its second International Symposium on
Tissue Technologies in Berlin, Germany on June 15 - 16, 2017.
Following the success of the first International
Tissue Technologies Symposium in 2016, Integra is holding a second
event, offering a two-day scientific symposium, which will bring
together more than 100 surgeons from Europe and the United States.
The 2017 International Symposium on Tissue Technologies will
present an overview of different surgical techniques used in
various medical fields, such as dermal reconstruction and
regeneration, and plastic and reconstructive procedures in breast
and complex abdominal wall repair. A faculty of world-renowned key
opinion leaders will join the meeting to share their experience and
viewpoints during the different scientific sessions and
discussions.
"As a world leader in regenerative technologies,
Integra is committed to offering a best-in-class medical education
platform that will enable physicians to benefit from the experience
of some of the world's leading plastic and reconstructive
surgeons," said Stephane Corp, Integra's vice president, Tissue
Technologies, Europe.
"We share with many surgeons a strong vision of
all the scientific benefits brought by the soft tissue repair
technologies. We believe that these technologies will continue to
help improve patients' lives, and we are proud to offer a forum
where practitioners can share best practices and techniques learned
from their personal experience with patients."
About Integra
Integra LifeSciences is dedicated to limiting uncertainty for
clinicians, so they can concentrate on providing the best patient
care. Integra offers innovative solutions, including leading
plastic and regenerative technologies, in specialty surgical
solutions, and orthopedics and tissue technologies. For more
information, please visit www.integralife.com.
This news release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 2016. Forward-looking statements include, but are not
limited to, statements concerning the products and services
provided by Integra. Such forward looking statements involve risks
and uncertainties that could cause actual results to differ
materially from predicted or expected results. Among other things,
the willingness of surgical professionals to use Integra products
may affect the prospects for their use in surgical procedures. In
addition, the economic, competitive, governmental, technological
and other factors, identified under the heading "Risk Factors"
included in Item IA of Integra's Annual Report on Form 10-K for the
year ended December 31, 2016 and information contained in
subsequent filings with the Securities and Exchange Commission
could affect actual results.
Contact Information:
Media:
Marie-Anne Girel (Europe)
+33 4 37 47 59 70
marie-anne.girel@integralife.com
Laurene Isip (U.S.)
+ 609 750 7984
laurene.isip@integralife.com
Investors:
Michael Beaulieu
+ 1 609 750 2827
michael.beaulieu@integralife.com
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Integra LifeSciences Holdings Corp. via
Globenewswire
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Feb 2024 to Mar 2024
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Mar 2023 to Mar 2024